GlaxoSmithKline Europe's largest drugmaker, will eliminate 1,000 sales positions in the U.S. as part of a plan to trim costs.
The jobs will be cut by the end of the year, Claire Brough, a company spokeswoman, said in a telephone interview today. Glaxo said in October 2007 that it would cut jobs in sales, manufacturing and research as part of a plan to save 700 million pounds ($1.12 billion) per year by 2010.
In June, the company said it planned to cut about 350 jobs in research and development in the U.S., U.K. and Italy.
More
No comments:
Post a Comment